Digging Deep for DD again.. Interesting

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Digging Deep for DD again..

Interesting find..

Professor Andreas Stallmach, Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Disease, Friedrich Schiller University of Jena, Germany Selects WavSTAT(R) Optical Biopsy System for Early Cancer Detection

Yes this was 2010, six years ago, but understand studies don't happen in a week. Nay-sayers want you to think so, but that doesnt change fact from fiction. It takes years to begin the study, then find participants, then do the study, then gather the data, then interpret the data. So, 6 years later here we are. It appears all of these studies have been just about completed

Quote:
the WavSTAT4 Optical Biopsy System(R) was once again found to exceed the clinical guidelines adopted by EU and US medical societies for the diagnosis of small and diminutive colorectal polyps during screening colonoscopies.


http://www.marketwired.com/press-release/spec...080220.htm

"Once again" implies other studies were performed, like the one above in 2010, and once again shows that the WavSTAT works. I think we're at a crossroads. Yes, SCIE has debt, but they have a product that works, and numerous studies which shows it works.

In addition, it was also said in 2010..

Quote:
An evaluation of the WavSTAT for detection of pre-cancers in the throat (Barrett's esophagus) is currently underway.


..and this opens a whole new door of possibilities for the WavSTAT.

Jump ahead 2 years from 2010 and we get this PR..

Quote:
SpectraScience to Exhibit WavSTAT4 Optical Biopsy System at Digestive Disease Week Conference


http://www.spectrascience.com/index.php/news/...tive-disea


Quote:
Fluorescence Spectroscopy Incorporated in an Optical Biopsy System (OBS) for the Detection of Early Neoplasia in Barrett's Esophagus (BE).” This live presentation on Sunday, May 20 at 4:45 p.m. by David Boerwinkel, MD (Dept. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands), provides results of endoscopies on 32 patients with Barrett’s esophagus in which areas suspicious for neoplasia and endoscopically inconspicuous areas were imaged with the WavSTAT OBS, followed by a correlating physical biopsy with the optical biopsy forceps for histological evaluation


The above quote proves SCIE did what they said they would do in 2010. 2 years later they presented and showed that the WavSTAT does work for Barrett’s esophagus patients.

Fast forward 4 years to today, and we have even more results to look forward to.

Nay-sayers are welcome to counter any/all of this, but be sure to include your own links disproving any of this. I wont hold my breath.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 4

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 5

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 7

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 3

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 2

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Changes at Aramis Group: New CEO for Clicars

Updated Category News Views 119

Exciting Leadership Transition at Aramis Group Aramis Group is thrilled to announce the appointment of Alejandro Garcia Mella as the new Chief Executive Officer of Clicars. This change in leadership comes as Alejandro steps into the role previously held by José Carlos del Valle, who has embarked on fresh professional ventures. Alejandro Garcia Mella: A Proven Leader...

Continue Reading
Exploring Hancock Whitney Corporation's Stock Growth Over 5 Years

Updated Category News Views 156

Overview of Hancock Whitney Corporation's Performance Hancock Whitney (NASDAQ: HWC) has shown impressive growth over the past five years. Investors who held onto their shares during this time would be pleased to know that they have consistently outperformed the market. Annualized Returns from HWC Stock The remarkable news is that Hancock Whitney has provided an average...

Continue Reading
Gantry Enhances Mortgage Banking with Triad Capital Acquisition

Updated Category News Views 91

Gantry got its hands on Triad Capital Advisors back in 2023, and it was no small move. This merger wasn't just about beefing up their operational muscle; it expanded Gantry's footprint in the Midwest finance scene big time. It’s like they dropped a bomb on their competitors without warning—traders watching closely could feel the shift coming. With this acquisition,...

Continue Reading
Mercury Insurance Stresses Cybersecurity Awareness Amid Threats

Updated Category News Views 316

Mercury Insurance Prioritizes Cybersecurity Recommendations Protect Yourself During National Cybersecurity Awareness Month In light of the rising concerns regarding cybercrime, Mercury Insurance (NYSE: MCY) emphasizes the importance of cybersecurity to safeguard personal and financial information. Recent reports indicate an alarming increase in cyberattacks, prompting a...

Continue Reading
Graphic Packaging Welcomes Alessandro Maselli to the Board

Updated Category News Views 212

Graphic Packaging Welcomes Alessandro Maselli to the Board Graphic Packaging Holding Company (NYSE: GPK), a renowned leader in sustainable consumer packaging, has exciting news about its board of directors. The company recently announced the appointment of Alessandro Maselli to its Board. This strategic decision is aligned with the company's commitment to enhancing...

Continue Reading